ERBB3 and neoplasm: Screening in ovarian cancer cells using lentivirally-delivered short hairpin RNA library targeting RTKs revealed ErbB3 as a relevant target and both genetic and pharmacological inhibition of the HRG/ErbB3 axis activation resulted in tumor growth inhibition7,22.